China's OTC Drug Market To Reach RMB 192.3 Billion In 2014
This article was originally published in PharmAsia News
China's OTC drug market expanded five-fold from 2000 to 2009 at RMB 120.95 billion, of which the hospital market and retail market accounted for RMB 48.71 billion and RMB 72.24 billion respectively, and is expected to reach RMB 192.3 billion in 2014, according to the figures from a China Nonprescription Medicines Association blue book
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.